In This Section

CIMM Steering Committee

Catherine J. Wu, MD
Chair

Catherine J. Wu, MD

(2024-2026)

Professor of Medicine, Harvard Medical School
Chief, Division of Stem Cell Transplantation and Cellular Therapies
Dana-Farber Cancer Institute
Department of Medical Oncology
Lavine Family Chair for Preventative Cancer Therapies
Institute Member, Broad Institute of MIT and Harvard
Boston, Massachusetts

Kunle Odunsi, MD, PhD
Past-Chair

Kunle Odunsi, MD, PhD

(2024-2025)

Director; Dean for Oncology
Biological Sciences Division
Professor of Obstetrics and Gynecology
University of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois

Rostyslav Bilyy, PhD, DrSci

Rostyslav Bilyy, PhD, DrSci

(2022-2025)

Professor of Cytology, Histology & Embryology Department
Head of Immunology Laboratory
Danylo Halytsky Lviv National Medical University
Lviv, Ukraine

Ivan M. Borrello, MD

Ivan M. Borrello, MD

(2023-2026)

Director
Multiple Myeloma, BMT and Cell Therapy
Tampa General Hospital
Tampa, Florida

Julie R. Brahmer, MD, MSc, FASCO

Julie R. Brahmer, MD, MSc, FASCO

(2024-2027)

The Marilyn Meyerhoff Professor of Thoracic Oncology
Co-Leader of Cancer Immunology Research Program
Co-Director of the Upper Aerodigestive Cancers Program
Director of the Johns Hopkins Kimmel Cancer Center on the Bayview Campus
Baltimore, Maryland

Tullia C. Bruno, PhD

Tullia C. Bruno, PhD

(2024-2027)

Assistant Professor of Immunology
University of Pittsburgh
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania

John F. DiPersio, MD, PhD

John F. DiPersio, MD, PhD

(2023-2026)

Virginia E. and Samuel J. Golman Professor of Medicine
Professor of Medicine and Pathology & Immunology
Director, Center for Gene and Cellular Immunotherapy
Washington University School of Medicine
St. Louis, Missouri

Thomas F. Gajewski, MD, PhD

Thomas F. Gajewski, MD, PhD

(2024-2027)

AbbVie Foundation Professor of Pathology
Professor of Medicine
Professor of Ben May Department of Cancer Research
University of Chicago
Chicago, Illinois

Stephen Gottschalk, MD

Stephen Gottschalk, MD

(2024-2027)

Chair, Department of BMT & Cellular Therapy
St Jude Children’s Research Hospital
Memphis, Tennessee

Jennifer L. Guerriero, PhD

Jennifer L. Guerriero, PhD

(2023-2026)

Assistant Professor, Harvard Medical School
Lead Investigator, Brigham and Women’s Hospital
Member, Breast Cancer, Dana-Farber/Harvard Cancer Center
Member, Harvard Immunology, Harvard Medical School
Boston, Massachusetts

Lawrence Fong, MD

Lawrence Fong, MD

(2022-2025)

Efim Guzik Distinguished Professor in Cancer Biology
Leader, Cancer Immunotherapy Program
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Susan Kaech, PhD

Susan Kaech, PhD

(2021-2024)

Professor and Director
NOMIS Center for Immunobiology and Microbial Pathogenesis
Salk Institute for Biological Sciences
La Jolla, California

Sherene Loi, MD, PhD

Sherene Loi, MD, PhD

(2022-2025)

Professor, University of Melbourne
Consultant Medical Oncologist
Breast Unit Head, Translational Breast Cancer Genomics and Therapeutics Lab
Breast Stream Lead, Parkville Precinct Cancer Clinical Trials Unit
National Breast Cancer Foundation of Australia Endowed Chair
Peter MacCallum Cancer Centre
Melbourne, Australia

Jeffrey S. Miller, MD

Jeffrey S. Miller, MD

(2023-2026)

Professor of Medicine
Section Head, BMT and Cell Therapy
Division of Hematology, Oncology and Transplantation
Deputy Director, Masonic Cancer Center
Roger L. and Lynn C. Headrick Family Chair in Cancer Therapeutics
University of Minnesota
Minneapolis, Minnesota

Karolina Palucka, MD, PhD

Karolina Palucka, MD, PhD

(2023-2026)

Professor
Director of the JAX Cancer Center
The Jackson Laboratory for Genomic Medicine
Farmington, Connecticut

Marco Ruella, MD

Marco Ruella, MD

(2022-2025)

Assistant Professor of Medicine
Scientific Director, Lymphoma Program
Division of Hematology and Oncology and Center for Cellular Immunotherapies
Perelman Center for Advanced Medicine
University of Pennsylvania,
Philadelphia, Pennsylvania

Jennifer A. Wargo, MD, MMSc

Jennifer A. Wargo, MD, MMSc

(2022-2025)

Endowed Professor
Surgical Oncology and Genomic Medicine
Program Director for PRIME TR
University of Texas MD Anderson Cancer Center
Houston, Texas